Clinical Study to Compare the Pharmacokinetics and Safety of Trastuzumab for Injection With Herceptin® in Healthy Male Volunteers

Clinical trial NCT05765357 · COMPLETED

Trial details

NCT number

NCT05765357

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Status

COMPLETED

Phase

Phase 1

Study type

INTERVENTIONAL

Start date

2017-07-16

Primary completion

2017-10-27

Enrollment

89

View on ClinicalTrials.gov